scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...869129Y |
P356 | DOI | 10.1371/JOURNAL.PONE.0069129 |
P932 | PMC publication ID | 3723739 |
P698 | PubMed publication ID | 23935936 |
P5875 | ResearchGate publication ID | 255737097 |
P2093 | author name string | Hui Yang | |
Jianzhong Bi | |||
Lifei Wei | |||
Zhaohong Xie | |||
Hongna Yang | |||
P2860 | cites work | Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells | Q21245299 |
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice | Q21562482 | ||
Epidemiology of Alzheimer disease | Q26865371 | ||
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester | Q28248444 | ||
Morris water maze: procedures for assessing spatial and related forms of learning and memory | Q28296351 | ||
Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice | Q28476571 | ||
FOXP3+ regulatory T cells in the human immune system | Q29307487 | ||
Mechanisms underlying inflammation in neurodegeneration | Q29617977 | ||
Regulatory T cells in CNS injury: the simple, the complex and the confused | Q30424827 | ||
Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. | Q34224955 | ||
Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides | Q34750587 | ||
Aire controls mesenchymal stem cell-mediated suppression in chronic colitis | Q35665164 | ||
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis | Q35865438 | ||
Microglia: phagocyte and glia cell. | Q35894049 | ||
Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology | Q35959633 | ||
Immunological applications of stem cells in type 1 diabetes | Q36666422 | ||
Regulatory T cells - a brief history and perspective | Q36986732 | ||
Regulatory T cells: how do they suppress immune responses? | Q37593768 | ||
Immunological and regenerative properties of cord blood stem cells | Q37744150 | ||
Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease. | Q37846242 | ||
Immunomodulatory properties and therapeutic application of mesenchymal stem cells | Q37847217 | ||
Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly | Q37945426 | ||
The role of regulatory T cells in neurodegenerative diseases | Q38035240 | ||
Review: systemic inflammation and Alzheimer's disease | Q38050498 | ||
Epidemiology of dementias and Alzheimer's disease. | Q38060443 | ||
Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity | Q38480730 | ||
Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 | ||
The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. | Q40071382 | ||
Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response | Q40078663 | ||
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources | Q42974571 | ||
Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. | Q43102091 | ||
Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism | Q43140862 | ||
Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease | Q48513598 | ||
The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease | Q48615135 | ||
Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. | Q51053512 | ||
Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. | Q51888370 | ||
Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. | Q53298716 | ||
A review: inflammatory process in Alzheimer's disease, role of cytokines. | Q53328528 | ||
PD1 Negative and PD1 Positive CD4+ T Regulatory Cells in Mild Cognitive Impairment and Alzheimer's Disease | Q57997425 | ||
Microglia in Alzheimer's disease | Q58701591 | ||
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord | Q78799982 | ||
Mesenchymal cells recruit and regulate T regulatory cells | Q80717999 | ||
A novel way to isolate MSCs from umbilical cords | Q84130266 | ||
FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy | Q84888368 | ||
Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains | Q85246354 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | stem cell transplantation | Q65592366 |
human umbilical cord mesenchymal stem cell | Q107296600 | ||
P304 | page(s) | e69129 | |
P577 | publication date | 2013-07-25 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice | |
P478 | volume | 8 |
Q36326816 | A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders |
Q93014137 | Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses |
Q36018333 | Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology |
Q38543215 | CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease. |
Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
Q92980515 | Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging |
Q92699153 | Decreased Netrin-1 and Correlated Th17/Tregs Balance Disorder in Aβ1-42 Induced Alzheimer's Disease Model Rats |
Q47882404 | Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice |
Q89018777 | Effects of mesenchymal stem cells transplantation on cognitive deficits in animal models of Alzheimer's disease: A systematic review and meta-analysis |
Q35837904 | Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis. |
Q28077869 | Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging |
Q36728537 | Human Cortical Neural Stem Cells Expressing Insulin-Like Growth Factor-I: A Novel Cellular Therapy for Alzheimer's Disease |
Q35548329 | Human mesenchymal stem cells - current trends and future prospective |
Q57041817 | Human neural stem cell transplantation improves cognition in a murine model of Alzheimer's disease |
Q60952623 | Impact and Challenges of Mesenchymal Stem Cells in Medicine: An Overview of the Current Knowledge |
Q36534248 | Matrine improves cognitive impairment and modulates the balance of Th17/Treg cytokines in a rat model of Aβ1-42-induced Alzheimer's disease |
Q38843840 | Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease |
Q37688368 | Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model |
Q57039635 | Peripheral immune system in aging and Alzheimer's disease |
Q38772566 | Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role? |
Q39084950 | Potential importance of B cells in aging and aging-associated neurodegenerative diseases |
Q46297701 | Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine |
Q44241652 | Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease |
Q36356181 | Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice |
Q99579313 | Stem cell therapy for Alzheimer's disease |
Q90627086 | Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks |
Q47602416 | Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models |
Q38274179 | T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases |
Q30819335 | The anti-aging effects of LW-AFC via correcting immune dysfunctions in senescence accelerated mouse resistant 1 (SAMR1) strain |
Q39295050 | The role of regulatory T cells in nervous system pathologies |
Q37687257 | Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study |
Q50577170 | Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model. |
Search more.